Training future experts in tobacco regulation
Official title: Career Enhancement Core
Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-10934556 · Data updated 2026-11-12
This study is all about helping students and new professionals learn the ins and outs of tobacco regulation through hands-on training and mentorship, so they can make a real difference in public health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project start | September 30, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $976,352 |
| NIH project number | 5U54DA058271-02 |
| Project ID | NIH-10934556 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include undergraduate and medical students, as well as early-career researchers interested in tobacco regulatory science.
✕Less likely to help
Patients who are not involved in academic or research training related to tobacco regulation may not receive direct benefits from this research.
What this research studies
This research focuses on developing the next generation of investigators in tobacco regulatory science by providing comprehensive training programs for students and early-career professionals. The Penn State Center for Research on Tobacco and Health offers a structured approach that includes hands-on research experiences, mentorship, and tailored educational components. Participants will engage in various programs designed for different career stages, from undergraduate students to new faculty members, ensuring a diverse and skilled workforce in tobacco regulation. The training encompasses both theoretical knowledge and practical laboratory skills to prepare trainees for impactful careers in this field.
Why it matters
Potential benefit: If successful, this research could lead to a more informed and effective regulation of tobacco products, ultimately improving public health outcomes.
How similar studies have gone: Previous initiatives in training programs for tobacco regulatory science have shown promise in enhancing the skills and knowledge of participants, indicating a positive trajectory for this approach.
Where this research is happening
-
Pennsylvania State Univ Hershey Med Ctr
Hershey, United States Active
Researchers
- Principal investigator: Hobkirk, Andrea — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Hobkirk, Andrea
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Understanding the STIM/Orai Calcium Signaling Pathway in Cancer
Researchers are studying how STIM and Orai proteins control calcium signals inside cells and how this affects cancer-related growth and remodeling, with hopes to find ways to influence these signals for better treatments.
-
Understanding how some Amish communities maintain high birth rates in modern times
A project will build a large, time-sensitive dataset to understand why Amish families keep having many children, even as broader society has much lower birth rates.
-
Scoliosis and neurosurgical factors in myelomeningocele: a clinic registry study
This project uses registry data from Penn State’s Spina Bifida Clinic to understand how brain and spine-related issues influence when and why scoliosis surgery is needed in people with myelomeningocele.
-
Understanding how damaged stomach cells revert to a repair state to prevent cancer
Researchers are studying how certain stomach cells re-enter the cell cycle to aid tissue repair, and how this process might lead to metaplasia or cancer if it goes wrong.
-
Aging, cell aging, and how MCPyV causes Merkel cell carcinoma
Aging and aging-related changes in skin cells may help a common virus (MCPyV) persist and potentially lead to a rare skin cancer in people with weaker immune systems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.